CORT Dec 2024 31.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 11:41AM EDT
Loading interactive chart…
- Zacks
Corcept (CORT) Up 24.5% Since Last Earnings Report: Can It Continue?
Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GuruFocus.com
Insider Sale: Chief Development Officer William Guyer Sells 30,000 Shares of Corcept ...
On May 28, 2024, William Guyer, the Chief Development Officer of Corcept Therapeutics Inc (NASDAQ:CORT), executed a sale of 30,000 shares of the company.
- Zacks
Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal
Corcept's (CORT) phase III GRACE study, evaluating its lead candidate, relacorilant, for treating patients with Cushing's syndrome, meets the primary endpoint in a randomized withdrawal phase.
© 2024 Yahoo. All rights reserved.